Kesin MAG-AL Plus XS

NDC 81033-007 · Kesin Pharma Corporation

Generic nameAluminum and Magnesium Hydroxide w/Simethicone Suspension

Dosage formSUSPENSION

RouteORAL

Active ingredient(s)DIMETHICONE, UNSPECIFIED, ALUMINUM HYDROXIDE, MAGNESIUM HYDROXIDE

Strength400; 40; 400 mg/5mL; mg/5mL; mg/5mL

Pharmacologic classCalculi Dissolution Agent [EPC], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Skin Barrier Activity [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]

Marketing categoryOTC MONOGRAPH DRUG

Packages

81033-007-01 — 100 CUP, UNIT-DOSE in 1 CASE (81033-007-01) / 30 mL in 1 CUP, UNIT-DOSE (81033-007-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

79903-431 — Zinc oxide, Dimethicone, 80447-649 — magnesium hydroxide, 80513-119 — Simethicone, 80661-003 — Magnesium Hydroxide,Magnesium Carbonate Hydroxide, 80661-004 — Magnesium Hydroxide,Magnesium Carbonate Hydroxide, 80661-005 — Magnesium Hydroxide,Magnesium Carbonate Hydroxide, 80661-006 — Magnesium Hydroxide,Magnesium Carbonate Hydroxide, 80661-007 — Magnesium Hydroxide,Magnesium Carbonate Hydroxide, 81033-005 — Aluminum and Magnesium Hydroxide Suspension, 81033-006 — Aluminum and Magnesium Hydroxide w/Simethicone Suspension, 81033-014 — Magnesium Hydroxide, 82442-321 — famotidine, calcium carbonate and magnesium hydroxide, 82442-546 — Famotidine, Calcium Carbonate, Magnesium Hydroxide, 82706-031 — Simethicone, 83324-121 — aluminum hydroxide, magnesium hydroxide, simethicone, 83324-122 — aluminum hydroxide, magnesium hydroxide, simethicone, 83324-125 — aluminum hydroxide, magnesium hydroxide, simethicone, 83324-188 — magnesium hydroxide, 83324-219 — aluminum hydroxide and magnesium carbonate, 83324-304 — Simethicone, +395 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels